SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: billkirn who wrote (710)5/9/1997 10:57:00 AM
From: billkirn   of 6136
 
Hate to be so negative since I just bought call options on AGPH, but
found article in Barons that puts Agph on the most dangerous
list based on its short position.

A quote from the article:

"In fact, after reviewing New York Stock Exchange short-interest data from 1977 through 1990, Professors Paul Asquith of MIT's Sloan School of Management and Lisa K. Muelbrook of Harvard Business School drew a simple conclusion about what to do with a heavily shorted stock: Sell it."

Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext